By Caroline Valetkevitch
(Reuters) - U.S. stocks rallied on Thursday after two days of losses, led by sharp gains in biotechnology shares and a rebound in financials following upbeat results from Citigroup.
Equities added to gains late in the session, and eight of the S&P 500 sectors registered gains of more than 1 percent. More than four stocks rose for every one that fell on both the New York Stock Exchange and the Nasdaq.
The S&P 500 health care index <.SPXHC> jumped 2.2 percent despite a disappointing forecast from HCA Holdings
""There's a lot of cash on sidelines, and we did break through to a new high since the August decline," said Tim Ghriskey, chief investment officer of Solaris Group in Bedford Hills, New York. "Volume picked up as well, which is a strong indicator."
Citigroup
More From This Section
The financial sector <.SPSY> jumped 2.3 percent, recovering from losses Wednesday when JPMorgan
U.S. consumer prices declined the most in eight months as gasoline costs fell in September, but a rise in core CPI, which strips out food and energy costs, suggested inflation was starting to firm. Unemployment benefit claims fell in the last week, pointing to a strong labour market.
The data, following a weak retail sales report, added to uncertainty over the timing of an interest rate increase by the Federal Reserve.
The Dow Jones industrial average <.DJI> rose 217 points, or 1.28 percent, to 17,141.75, the S&P 500 <.SPX> gained 29.62 points, or 1.49 percent, to 2,023.86 and the Nasdaq Composite <.IXIC> added 87.25 points, or 1.82 percent, to 4,870.10.
Nike
On the downside, Netflix
The S&P 500 posted 11 new 52-week highs and 7 new lows; the Nasdaq recorded 42 new highs and 41 new lows.
About 7.0 billion shares changed hands on U.S. exchanges, below the 7.6 billion daily average for the past 20 trading days, according to Thomson Reuters data.
(Additional reporting by Abhiram Nandakumar in Bengaluru; Editing by Saumyadeb Chakrabarty and Nick Zieminski)